In Iceland, Debate Simmers Over Imputed Genotypes, Preventive Medicine, and Public Health | GenomeWeb

NEW YORK (GenomeWeb) – With the push of a button, DeCode Genetics CEO Kári Stefánsson claims he could identify everyone in Iceland who carries gene mutations linked to elevated cancer risk, and would be keen to work with partners in the healthcare sector to reach those people.

Yet questions about the ethics of alerting people to their cancer risk without their consent have so far frustrated DeCode Genetics' vision of using genetics to improve public health in the island country.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.